USPSTF2018EN
USPSTF Recommendation: Screening for Osteoporosis
Zusammenfassung
Final Recommendation Statement: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce Skip to main content Search the USPSTF Site Button Subscribe Toggle navigation Search the USPSTF Site Button Recommendations Search and Filter All Recommendations Standards for Guideline Development Grade Definitions USPSTF A&B Recommendations USPSTF Recommendations App - Prevention TaskForce Public Comments and Nominations Opportunity for Public Comment Nominate a New USPST
Kerninformationen
Download Final Recommendation Statement (PDF) Return to Recommendation Table of Contents Preamble Importance USPSTF Assessment of Magnitude of Net Benefit Practice Considerations Update of Previous USPSTF Recommendation Supporting Evidence Research Needs and Gaps Authors of the Recommendation Statem...
Morbidity from fragility fractures at central skeletal sites, particularly the hip, is much greater than morbidity from fragility fractures at other sites. 1 Evidence shows that only 40% to 60% of persons experiencing a hip fracture recover their prefracture level of mobility and ability to perform ...
In describing the evidence, sex terms are reported as used by study authors, which are typically “men” and “women.” Transgender men and transgender women who have not undergone any hormonal treatment associated with transitioning likely have the same risks as persons assigned female and male sex at ...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
RACGP2024
Osteoporosis management and fracture prevention in post-menopausal women and men over 50 years of age
USPSTF2025
Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
SIGN2021
SIGN 142: Management of Osteoporosis and the Prevention of Fragility Fractures
USPSTF2018
USPSTF: Osteoporosis: Screening to Prevent Fractures (Grade B, 2018)
AWMF2023
AWMF 183-001: Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern ab dem 50. Lebensjahr
Cochrane2025
Cochrane Review: Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
Dachverband Osteologie (DVO) / AWMF2023